Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma.
暂无分享，去创建一个
D. Schadendorf | P. Ascierto | C. Blank | M. Mandalà | J. Grob | R. Gutzmer | P. Rutkowski | G. Long | P. Lorigan | S. Gandini | M. Carlino | A. Haydon | S. Suciu | A. van den Eertwegh | V. Atkinson | M. Kicinski | A. Eggermont | S. Valpione | O. Kennedy | C. Robert | A. Khattak | A. Meshcheryakov | A. D. Di Giacomo | M. Boers-Sonderen | R. Jamal | J. Larkin | S. Sandhu | S. Puig | A. V. van Akkooi | Stéphane Dalle